When are breakthrough therapies cost-effective?

por Olchanski, Natalia, Lin, Pei-Jung, Yeh, Wei-Shi, Kowal, Stacey, Cohen, Joshua T
Publicado 2022

Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study

por Qian, Ying, McGraw, Sarah, Henne, Jeff, Jarecki, Jill, Hobby, Kenneth, Yeh, Wei-Shi
Publicado 2015

A qualitative study of perceptions of meaningful change in spinal muscular atrophy

por McGraw, Sarah, Qian, Ying, Henne, Jeff, Jarecki, Jill, Hobby, Kenneth, Yeh, Wei-Shi
Publicado 2017

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study

por Cohan, Stanley, Smoot, Kyle, Kresa-Reahl, Kiren, Garland, Robert, Yeh, Wei-Shi, Wu, Ning, Watson, Crystal
Publicado 2018

Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database

por Boster, Aaron, Nicholas, Jacqueline, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Edwards, Michael, Huang, Ming-Yi, Lee, Andrew
Publicado 2017

Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data

por Nicholas, Jacqueline, Boster, Aaron, Wu, Ning, Yeh, Wei-Shi, Fay, Monica, Kendter, Jon, Huang, Ming-Yi, Lee, Andrew
Publicado 2017